- Home
- SBFG vs ANIX Comparison
SBFG vs ANIX Comparison
Compare SBFG & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFG
- ANIX
- Stock Information
- Founded
- SBFG 1983
- ANIX 1982
- Country
- SBFG United States
- ANIX United States
- Employees
- SBFG N/A
- ANIX N/A
- Industry
- SBFG Major Banks
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- SBFG Finance
- ANIX Health Care
- Exchange
- SBFG Nasdaq
- ANIX Nasdaq
- Market Cap
- SBFG 133.1M
- ANIX 135.3M
- IPO Year
- SBFG N/A
- ANIX 1987
- Fundamental
- Price
- SBFG $21.65
- ANIX $4.66
- Analyst Decision
- SBFG
- ANIX Strong Buy
- Analyst Count
- SBFG 0
- ANIX 3
- Target Price
- SBFG N/A
- ANIX $9.00
- AVG Volume (30 Days)
- SBFG 14.0K
- ANIX 163.3K
- Earning Date
- SBFG 10-30-2025
- ANIX 01-09-2026
- Dividend Yield
- SBFG 2.88%
- ANIX N/A
- EPS Growth
- SBFG 21.17
- ANIX N/A
- EPS
- SBFG 2.11
- ANIX N/A
- Revenue
- SBFG $63,406,000.00
- ANIX N/A
- Revenue This Year
- SBFG N/A
- ANIX N/A
- Revenue Next Year
- SBFG N/A
- ANIX N/A
- P/E Ratio
- SBFG $10.18
- ANIX N/A
- Revenue Growth
- SBFG 11.76
- ANIX N/A
- 52 Week Low
- SBFG $17.10
- ANIX $2.07
- 52 Week High
- SBFG $24.48
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- SBFG 60.29
- ANIX 62.44
- Support Level
- SBFG $19.67
- ANIX $4.15
- Resistance Level
- SBFG $20.37
- ANIX $4.59
- Average True Range (ATR)
- SBFG 0.90
- ANIX 0.26
- MACD
- SBFG 0.10
- ANIX 0.01
- Stochastic Oscillator
- SBFG 73.70
- ANIX 93.59
About SBFG SB Financial Group Inc.
SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in single segment which is Banking.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.